Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Approvable letter issued for Foradil Certihaler

Oct. 24, 2003

Baxter completes acquisition of Aralast

Oct. 24, 2003

AVP-13358 well tolerated in phase I trial

Oct. 24, 2003

New muscarinic M3 antagonists covered by Boehringer Ingelheim patent

Oct. 24, 2003

AstraZeneca describes a novel series of dual CCR3 modulators/H1 antagonists

Oct. 24, 2003

BMS scientists discover novel CCR2 antagonists for asthma, multiple sclerosis, arthritis, etc.

Oct. 21, 2003

New CCR3 antagonists and their use described by Toray and Yamanouchi

Oct. 21, 2003

Optically active IKK-beta inhibitor covered by Bayer patent

Oct. 20, 2003

Bayer presents new p38 kinase inhibitors for COPD therapy

Oct. 15, 2003

Potassium channel-modulating series described by 4SC researchers

Oct. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...